Are You Up to Date With the Latest FDA Guidance?

The US Food and Drug Administration (FDA) has issued guidance for excipients deemed to be at high risk of ethylene glycol or diethylene glycol contamination. This webinar will provide insights into legal and scientific constraints, as well as how to ensure safety during the production of pharmaceutical products.

Register Free: https://www.pharmexec.com/pe_w/fda-guidance

Event Overview:

The US Food and Drug Administration (FDA) recently issued guidance for excipients deemed at high risk of ethylene glycol or diethylene glycol contamination.

MedicinesComplete provides quick and easy access to a central source of trusted, expert information on medicines, including Pharmaceutical Excipients, the authoritative guide to the properties for excipients, their safe use, and their application.

Updated regularly online, this product has been revised to include safety content for all high-risk excipients to support your organization’s compliance with FDA guidance.

Essential knowledge through MedicinesComplete, including Martindale: The Complete Drug Reference, Pharmaceutical Excipients, Stockley’s Drug Interactions and BNF help industry professionals:

• Advise on legal and scientific constraints;
• Ensure the production of safe and efficacious treatments for patients, and;
• Assess the safety profile of pharmaceutical products.

Key Learning Objectives

• Learn how to advise on legal and scientific constraints.
• Learn how to ensure the production of safe and efficacious treatments for patients.
• Know how to assess the safety profile of pharmaceutical products.
• Stay ahead of evolving guidelines with regularly updated content.

Who Should Attend

• Medical affairs professionals
• Medical information professionals
• Healthcare professionals

Speaker

Morgane Brun
Senior International Account Manager
Pharmaceutical Press

Register Free:https://www.pharmexec.com/pe_w/fda-guidance